Vasa Adhatoda vasica: Respiratory Herb with 2026 Antiviral Research Data

Dr. Meera Iyer — Sun, 19 Jul 2026 06:00:00 +0000

Vasa (Adhatoda vasica): Respiratory Herb and Emerging Antiviral Research

Vasa (Adhatoda vasica Nees), widely known in Ayurveda as Vasaka or Vasa, is one of the important respiratory herbs used for Kasa (cough) and Shwasa (breathlessness or dyspnea). Classical Ayurvedic pharmacology describes it as bitter, astringent, cooling, and Kapha-Pitta balancing, while modern pharmacology has focused on its quinazoline alkaloids, especially vasicine and vasicinone. Together, these two perspectives explain why Vasa has remained central in Ayurvedic respiratory care for productive cough, inflammatory airway irritation, and mucus-associated breathing difficulty.

This article reviews Vasa’s verified Ayurvedic profile, its key respiratory phytochemistry, the clinically relevant forms in which it is used, and the current scope of antiviral investigation involving respiratory pathogens such as SARS-CoV-2 and influenza. Vasa should be understood as a traditional respiratory support herb used under proper guidance, not as a replacement for emergency care, prescribed inhalers, antivirals, antibiotics, or physician-directed treatment for serious respiratory disease.

Botanical Identity and Classical Description

The Ayurvedic Pharmacopoeia of India identifies Vasa as the fresh or dried mature leaves of Adhatoda vasica Nees of the Acanthaceae family. The plant is described as a sub-herbaceous bush found throughout the plains and sub-Himalayan tracts of India, ascending up to about 1,200 metres. Its leaves are lanceolate to ovate-lanceolate and have a characteristically bitter taste.

Classical names recorded for Vasa include Vṛṣa, Ātarūṣa, and Vāsaka. In practical Ayurvedic use, the leaf is the primary drug material, especially for juice, decoction, avaleha, and fermented preparations used in respiratory disorders.

Rasa (taste): Tikta (bitter), Kaṣāya (astringent)
Guna (quality): Laghu (light)
Virya (potency): Śīta (cooling)
Vipaka (post-digestive effect): Kaṭu (pungent)
Karma (actions): Hṛdya, Kaphapittahara, Raktasaṅgrāhika, Kāsaghna
Important formulations: Vāsakāsava and Vāsāvaleha
Therapeutic uses listed in the pharmacopoeial monograph: Śvāsa, Kāsa, Kṣaya, Raktapitta, Kāmalā, Kuṣṭha, and Prameha

Ayurvedic Respiratory Rationale

Vasa’s bitter-astringent taste, cooling potency, and Kapha-Pitta balancing action make it especially relevant where cough is associated with mucus, heat, irritation, bleeding tendency, or inflammatory congestion. The term Kāsaghna directly marks its traditional role in cough, while its listing for Śvāsa places it within the Ayurvedic respiratory materia medica for breathing difficulty.

This does not make Vasa a universal cough remedy. Ayurvedic respiratory treatment depends on the pattern of dosha, strength of the patient, season, digestive capacity, chronicity, and associated symptoms. A dry, cold, Vata-dominant cough, an acute asthma attack, pneumonia, tuberculosis-like wasting, or breathlessness with low oxygen saturation requires individualized assessment rather than casual self-use of any herb.

Key Alkaloids: Vasicine and Vasicinone

The Ayurvedic Pharmacopoeia of India lists alkaloids and essential oil among the constituents of Vasa leaves. Modern phytochemical work has particularly emphasized vasicine, also known as peganine, and vasicinone. These quinazoline alkaloids are central to the modern respiratory interpretation of Vasa.

Vasicinone was identified as a bronchodilator alkaloid from Adhatoda vasica, and later pharmacological work on related quinazoline alkaloids described antitussive, expectorant, and bronchodilating activity. This aligns with Vasa’s traditional use in cough and breathlessness without needing to reduce the herb to a single isolated compound. In Ayurvedic practice, the whole preparation, dose, vehicle, and clinical context remain important.

Vasa also has a notable place in the history of modern respiratory drugs. Bromhexine, a synthetic mucoactive drug used in productive cough, was developed as a derivative inspired by vasicine-related chemistry from Adhatoda vasica. This does not mean Vasa and bromhexine are interchangeable, but it illustrates how the plant’s traditional respiratory reputation led to pharmacological exploration of mucus clearance and airway support.

Expectorant and Mucoactive Profile

Vasa is traditionally used in forms that suit mucus-associated respiratory conditions: fresh leaf juice, decoction, avaleha, and fermented preparations. The fresh juice form is especially prominent in classical-style practice because it directly uses the mature leaf, while avaleha and asava forms are better suited to longer administration under supervision.

The modern mucoactive context around vasicine-derived chemistry supports the long-standing Ayurvedic use of Vasa where cough is productive and the respiratory passages require clearing. In practical terms, Vasa is most often considered when Kapha is involved in the airway picture, especially when accompanied by Pitta features such as heat, inflammation, yellowish sputum, throat irritation, or bleeding tendency. The exact form and dose should be chosen by a qualified practitioner rather than copied from a general article.

Anti-Inflammatory and Hypoxia-Linked Respiratory Work

Respiratory illness often combines mucus burden, airway constriction, epithelial irritation, and inflammatory signaling. Preclinical work involving Adhatoda vasica has examined inflammatory and hypoxia-linked markers in models relevant to severe airway disease and COVID-like respiratory stress. These investigations fit the broader picture of Vasa as a respiratory herb rather than a simple cough suppressant.

In clinical respiratory use, this wider profile matters because productive cough, bronchial irritation, post-viral airway sensitivity, and breathlessness may overlap. Ayurvedic use still requires diagnosis of the pattern and severity: Vasa may be appropriate in some Kapha-Pitta respiratory patterns, while other patterns require warming, lubricating, strengthening, antimicrobial, or emergency interventions.

Emerging Antiviral Research: SARS-CoV-2 and Influenza

Interest in Vasa’s antiviral potential increased after the COVID-19 pandemic, especially because the herb already had a traditional respiratory role. Computational work has modeled constituents of Adhatoda vasica against SARS-CoV-2 targets such as ACE2-related entry pathways and the viral main protease. Such work is useful for hypothesis generation, but it is not the same as demonstrating clinical antiviral efficacy.

A randomized open-label clinical study in mild or no-symptom COVID-19 compared Vasa ghan, Guduchi ghan, and a Vasa-Guduchi combination. The Vasa arm used 500 mg twice daily for 14 days, while the combination arm had a shorter mean viral clearance time than the individual-herb arms. The study also reported changes in inflammatory and hypoxia-linked biomarkers and did not report adverse effects in the enrolled participants. Because the study was open-label and did not include a placebo arm, Vasa should be regarded as an adjunctive respiratory support herb under professional care, not as a stand-alone COVID-19 treatment.

For influenza, in vitro work has examined aqueous and methanolic extracts of Justicia adhatoda/Adhatoda vasica against influenza virus using hemagglutination reduction methods. The methanolic extract showed strong inhibition in the tested laboratory conditions at higher extract concentrations, and the authors proposed interference with viral attachment or replication. This supports continued investigation of Vasa extracts in respiratory viral contexts, while clinical use for influenza must remain guided by medical severity, risk status, timing, and standard care.

Clinical Formulations and Traditional Use

The most practical Ayurvedic use of Vasa is not limited to isolated vasicine. Classical and pharmacopoeial preparations use the leaf in different dosage forms so that the physician can match the preparation to the patient, disease stage, digestive strength, and associated dosha pattern.

Preparation	Verified classical or pharmacopoeial context	Practical respiratory relevance
Vasa Swarasa	Fresh leaf juice; pharmacopoeial adult dose 10–20 mL	Used traditionally where fresh leaf juice is appropriate for cough and respiratory irritation under practitioner guidance
Vasa Kwatha	Dried drug for decoction; pharmacopoeial dose 10–20 g of dried drug	Used where a decoction form is preferred for Kapha-Pitta respiratory patterns
Vāsakāsava	Listed as an important formulation in the Ayurvedic Pharmacopoeia of India monograph for Vasa	Fermented preparation used in traditional respiratory care according to constitution and condition
Vāsāvaleha	Listed as an important formulation in the Ayurvedic Pharmacopoeia of India monograph for Vasa	Linctus-style preparation traditionally used for cough, throat irritation, and respiratory weakness patterns
Kanakāsava	Compound formulation traditionally described with ingredients such as Vasa, Kantakari, Yashtimadhu, Pippali, Bharangi, Shunthi, Talisapatra, Draksha, Dhataki, and others	Used traditionally in cough and asthma-like respiratory conditions under professional supervision

Clinical literature on Vasa formulations in Tamaka Shwasa has examined preparations such as Vasa Ghana, Vasa Ghrita, and Vasa Avaleha. Another clinical comparison evaluated Vasa Avaleha and granule forms in asthma-like presentations. These works are relevant to traditional formulation use, but they should not be read as permission to self-treat asthma, chronic bronchitis, COVID-19, influenza, pneumonia, or unexplained breathlessness.

Integration with Ayurvedic Respiratory Care

In Ayurvedic practice, Vasa is commonly integrated into broader respiratory protocols rather than used as a one-herb solution. The practitioner may combine it with herbs that support digestion, mucus clearance, throat comfort, immune resilience, or tissue recovery, depending on the clinical picture. For example, Pippali may be used in some cough formulas, while demulcent or nourishing herbs may be needed when dryness, depletion, or Vata aggravation is more prominent.

The vehicle also matters. Honey, warm water, decoction, ghee-based preparations, avaleha, and fermented preparations all change the way a respiratory herb is delivered and tolerated. Because Vasa is cooling and Kapha-Pitta balancing, excessive or poorly matched use may not suit every cough type, especially where the person is weak, cold, dry, pregnant, very young, elderly, or already using respiratory medicines.

Safety and Practitioner Guidance

Vasa requires caution in pregnancy. Vasicine has been reported as a uterotonic and abortifacient alkaloid in experimental literature, and Vasa preparations should be avoided during pregnancy unless a qualified physician specifically advises otherwise. People who are breastfeeding, children, elderly patients, and anyone with chronic lung disease should use Vasa only with professional guidance.

Seek urgent medical care for severe breathlessness, chest pain, bluish lips, confusion, high fever, blood in sputum, low oxygen saturation, wheezing not relieved by prescribed medication, suspected pneumonia, tuberculosis symptoms, COVID-19 complications, or worsening asthma. Vasa may have a place in Ayurvedic respiratory support, but it must not delay appropriate diagnosis, emergency care, oxygen support, inhalers, antibiotics, antivirals, or other medically necessary treatment.

Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified Ayurvedic physician or licensed healthcare provider before using Vasa or any herbal preparation for respiratory symptoms. Do not self-treat serious respiratory infections, asthma, COPD, pregnancy-related symptoms, or unexplained breathlessness.

Summary

Vasa remains a well-established Ayurvedic respiratory herb for Kasa and Shwasa, with a verified classical profile of Tikta-Kaṣāya rasa, Laghu guna, Śīta virya, Kaṭu vipaka, and Kaphapittahara-Kāsaghna action. Modern pharmacology supports its respiratory relevance through the study of vasicine, vasicinone, and related quinazoline alkaloids with bronchodilating, antitussive, expectorant, and mucoactive significance.

The antiviral picture is best described as emerging rather than settled. Computational SARS-CoV-2 work, an open-label COVID-19 clinical study, and in vitro influenza work all support further investigation, but they do not make Vasa a stand-alone antiviral therapy. Its strongest role remains as a professionally guided Ayurvedic respiratory herb, especially where cough, mucus, Pitta-Kapha irritation, and airway support are central to the clinical picture.

Vasicine – Ayurved Healing